A subsidiary of the Dallas-based biotech Lantern Pharma received federal approval to move ahead with its planned trial for a ...
ThreatsDay Bulletin covers stealthy attack trends, evolving phishing tactics, supply chain risks, and how familiar tools are ...
And more useful than I thought.